FDA Issues Warning Letter to ARG Laboratories
July 17, 2024
July 17, 2024
WASHINGTON, July 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to ARG Laboratories Inc.:
* * *
To: Darin Hoogendoorn, President, ARG Laboratories, Inc., 2639 Manana Drive, Dallas, TX 75220-1301, United States
Dear Mr. Hoogendoorn:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, ARG Laboratories, Inc., FEI 3002556034, at 2639 Manana . . .
* * *
To: Darin Hoogendoorn, President, ARG Laboratories, Inc., 2639 Manana Drive, Dallas, TX 75220-1301, United States
Dear Mr. Hoogendoorn:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, ARG Laboratories, Inc., FEI 3002556034, at 2639 Manana . . .